nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—breast cancer—colon cancer	0.897	1	CtDrD
Fluoxymesterone—AR—scrotum—colon cancer	0.0114	0.315	CbGeAlD
Fluoxymesterone—PRLR—liver—colon cancer	0.0033	0.0912	CbGeAlD
Fluoxymesterone—ESR1—blood vessel—colon cancer	0.00182	0.0503	CbGeAlD
Fluoxymesterone—Coma hepatic—Capecitabine—colon cancer	0.00134	0.215	CcSEcCtD
Fluoxymesterone—ESR1—embryo—colon cancer	0.00109	0.03	CbGeAlD
Fluoxymesterone—AR—epithelium—colon cancer	0.000902	0.0249	CbGeAlD
Fluoxymesterone—ESR1—epithelium—colon cancer	0.000886	0.0245	CbGeAlD
Fluoxymesterone—SHBG—bone marrow—colon cancer	0.000882	0.0244	CbGeAlD
Fluoxymesterone—AR—smooth muscle tissue—colon cancer	0.00087	0.024	CbGeAlD
Fluoxymesterone—ESR1—smooth muscle tissue—colon cancer	0.000854	0.0236	CbGeAlD
Fluoxymesterone—SHBG—vagina—colon cancer	0.000845	0.0233	CbGeAlD
Fluoxymesterone—AR—renal system—colon cancer	0.000837	0.0231	CbGeAlD
Fluoxymesterone—ESR1—renal system—colon cancer	0.000822	0.0227	CbGeAlD
Fluoxymesterone—NR3C1—embryo—colon cancer	0.000801	0.0221	CbGeAlD
Fluoxymesterone—SHBG—liver—colon cancer	0.000713	0.0197	CbGeAlD
Fluoxymesterone—AR—lymphoid tissue—colon cancer	0.000695	0.0192	CbGeAlD
Fluoxymesterone—AR—digestive system—colon cancer	0.000687	0.019	CbGeAlD
Fluoxymesterone—ESR1—lymphoid tissue—colon cancer	0.000682	0.0189	CbGeAlD
Fluoxymesterone—ESR1—digestive system—colon cancer	0.000674	0.0186	CbGeAlD
Fluoxymesterone—NR3C1—epithelium—colon cancer	0.000654	0.0181	CbGeAlD
Fluoxymesterone—NR3C1—smooth muscle tissue—colon cancer	0.00063	0.0174	CbGeAlD
Fluoxymesterone—AR—vagina—colon cancer	0.000606	0.0168	CbGeAlD
Fluoxymesterone—NR3C1—renal system—colon cancer	0.000606	0.0168	CbGeAlD
Fluoxymesterone—Oligospermia—Methotrexate—colon cancer	0.000596	0.0956	CcSEcCtD
Fluoxymesterone—ESR1—vagina—colon cancer	0.000595	0.0164	CbGeAlD
Fluoxymesterone—AR—liver—colon cancer	0.000511	0.0141	CbGeAlD
Fluoxymesterone—NR3C1—lymphoid tissue—colon cancer	0.000503	0.0139	CbGeAlD
Fluoxymesterone—ESR1—liver—colon cancer	0.000502	0.0139	CbGeAlD
Fluoxymesterone—NR3C1—digestive system—colon cancer	0.000497	0.0137	CbGeAlD
Fluoxymesterone—Azoospermia—Methotrexate—colon cancer	0.000464	0.0744	CcSEcCtD
Fluoxymesterone—NR3C1—bone marrow—colon cancer	0.000458	0.0127	CbGeAlD
Fluoxymesterone—NR3C1—vagina—colon cancer	0.000439	0.0121	CbGeAlD
Fluoxymesterone—AR—lymph node—colon cancer	0.000392	0.0108	CbGeAlD
Fluoxymesterone—ESR1—lymph node—colon cancer	0.000385	0.0106	CbGeAlD
Fluoxymesterone—NR3C1—liver—colon cancer	0.00037	0.0102	CbGeAlD
Fluoxymesterone—Hirsutism—Capecitabine—colon cancer	0.000289	0.0463	CcSEcCtD
Fluoxymesterone—NR3C1—lymph node—colon cancer	0.000284	0.00785	CbGeAlD
Fluoxymesterone—Megestrol acetate—ABCB1—colon cancer	0.00022	0.157	CrCbGaD
Fluoxymesterone—Coagulopathy—Capecitabine—colon cancer	0.000216	0.0346	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Irinotecan—colon cancer	0.000188	0.0302	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.000175	0.00295	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CCND1—colon cancer	0.000175	0.00294	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CTNNB1—colon cancer	0.000173	0.00292	CbGpPWpGaD
Fluoxymesterone—Triamcinolone—PTGS2—colon cancer	0.000167	0.119	CrCbGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—AKT1—colon cancer	0.000167	0.00281	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—EP300—colon cancer	0.000167	0.00281	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—SRC—colon cancer	0.000166	0.00279	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—AKT1—colon cancer	0.000164	0.00275	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000163	0.00275	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000162	0.00273	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—EP300—colon cancer	0.000161	0.00271	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NRAS—colon cancer	0.000159	0.00268	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—KRAS—colon cancer	0.000157	0.00264	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000155	0.00262	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000151	0.00254	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000147	0.00248	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MYC—colon cancer	0.000146	0.00245	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000145	0.00245	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—PIK3CA—colon cancer	0.000144	0.00243	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MYC—colon cancer	0.000143	0.00241	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000142	0.00239	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—colon cancer	0.000141	0.00237	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00014	0.00236	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—colon cancer	0.000139	0.00235	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000139	0.00235	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—colon cancer	0.000138	0.00233	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CCND1—colon cancer	0.000138	0.00233	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—KRAS—colon cancer	0.000137	0.00231	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PTGS2—colon cancer	0.000137	0.0974	CrCbGaD
Fluoxymesterone—Spironolactone—ABCB1—colon cancer	0.000137	0.0973	CrCbGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—EP300—colon cancer	0.000137	0.0023	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000135	0.00228	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000135	0.00227	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD8A—colon cancer	0.000134	0.00226	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000134	0.00226	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—colon cancer	0.000134	0.00225	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—SRC—colon cancer	0.000133	0.00224	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—EP300—colon cancer	0.000133	0.00223	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000133	0.00223	CbGpPWpGaD
Fluoxymesterone—Libido decreased—Capecitabine—colon cancer	0.000131	0.0211	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—colon cancer	0.00013	0.00218	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—colon cancer	0.00013	0.00218	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCND1—colon cancer	0.000129	0.00218	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	0.000128	0.00216	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CTNNB1—colon cancer	0.000128	0.00215	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—EP300—colon cancer	0.000127	0.00214	CbGpPWpGaD
Fluoxymesterone—Norethindrone—ABCB1—colon cancer	0.000127	0.0904	CrCbGaD
Fluoxymesterone—Haemoglobin—Irinotecan—colon cancer	0.000127	0.0203	CcSEcCtD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—colon cancer	0.000126	0.00212	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Irinotecan—colon cancer	0.000126	0.0202	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000125	0.00211	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CDKN1A—colon cancer	0.000125	0.00211	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BAX—colon cancer	0.000125	0.0021	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CCND1—colon cancer	0.000124	0.00208	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Fluorouracil—colon cancer	0.000121	0.0194	CcSEcCtD
Fluoxymesterone—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000121	0.0194	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCND1—colon cancer	0.000121	0.00203	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Fluorouracil—colon cancer	0.000121	0.0193	CcSEcCtD
Fluoxymesterone—NR3C1—Endoderm Differentiation—CTNNB1—colon cancer	0.00012	0.00203	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CTNNB1—colon cancer	0.00012	0.00201	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—EP300—colon cancer	0.000119	0.00201	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EP300—colon cancer	0.000119	0.002	CbGpPWpGaD
Fluoxymesterone—Prednisolone—ABCB1—colon cancer	0.000119	0.0845	CrCbGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—colon cancer	0.000119	0.002	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CTNNB1—colon cancer	0.000118	0.00198	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—colon cancer	0.000117	0.00198	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—colon cancer	0.000117	0.00196	CbGpPWpGaD
Fluoxymesterone—Betamethasone—ABCB1—colon cancer	0.000116	0.0828	CrCbGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000116	0.00195	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—SRC—colon cancer	0.000116	0.00195	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—BCL2L1—colon cancer	0.000115	0.00194	CbGpPWpGaD
Fluoxymesterone—Alopecia—Vincristine—colon cancer	0.000114	0.0183	CcSEcCtD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—colon cancer	0.000114	0.00192	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.000114	0.00191	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—HNF4A—colon cancer	0.000113	0.0019	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—colon cancer	0.000113	0.0019	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	0.000112	0.00188	CbGpPWpGaD
Fluoxymesterone—Gynaecomastia—Methotrexate—colon cancer	0.000112	0.0179	CcSEcCtD
Fluoxymesterone—Alopecia—Irinotecan—colon cancer	0.000111	0.0178	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EP300—colon cancer	0.000111	0.00187	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FGFR3—colon cancer	0.00011	0.00185	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EP300—colon cancer	0.000109	0.00184	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000109	0.00184	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000107	0.00181	CbGpPWpGaD
Fluoxymesterone—Alopecia—Fluorouracil—colon cancer	0.000107	0.0171	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.000106	0.00179	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—colon cancer	0.000104	0.00175	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000104	0.00175	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.000103	0.00174	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FGFR3—colon cancer	0.000103	0.00173	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—colon cancer	0.000103	0.00173	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—colon cancer	0.000102	0.00172	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000102	0.00172	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—SRC—colon cancer	0.000102	0.00172	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—PPARG—colon cancer	0.000102	0.00172	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—colon cancer	0.000101	0.00171	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—colon cancer	0.000101	0.00171	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—colon cancer	9.91e-05	0.00167	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	9.89e-05	0.00166	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—colon cancer	9.89e-05	0.00166	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—colon cancer	9.74e-05	0.00164	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—colon cancer	9.74e-05	0.00164	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—colon cancer	9.73e-05	0.00164	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—colon cancer	9.69e-05	0.00163	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—colon cancer	9.68e-05	0.00163	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—colon cancer	9.66e-05	0.00163	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—EP300—colon cancer	9.64e-05	0.00162	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	9.59e-05	0.00161	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—colon cancer	9.54e-05	0.0016	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—colon cancer	9.51e-05	0.0016	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Methotrexate—colon cancer	9.37e-05	0.015	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—CDH1—colon cancer	9.29e-05	0.00156	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Vincristine—colon cancer	9.18e-05	0.0147	CcSEcCtD
Fluoxymesterone—Hydrocortisone—ABCB1—colon cancer	9.09e-05	0.0647	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Irinotecan—colon cancer	8.94e-05	0.0144	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—BRAF—colon cancer	8.94e-05	0.0015	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CDH1—colon cancer	8.75e-05	0.00147	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—HNF4A—colon cancer	8.7e-05	0.00146	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—colon cancer	8.7e-05	0.00146	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	8.62e-05	0.00145	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—HNF4A—colon cancer	8.57e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Fluorouracil—colon cancer	8.57e-05	0.0137	CcSEcCtD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—colon cancer	8.48e-05	0.00143	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—colon cancer	8.48e-05	0.00143	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—colon cancer	8.47e-05	0.00143	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Capecitabine—colon cancer	8.47e-05	0.0136	CcSEcCtD
Fluoxymesterone—Haemorrhage—Capecitabine—colon cancer	8.43e-05	0.0135	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	8.39e-05	0.00141	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Vincristine—colon cancer	8.25e-05	0.0132	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—colon cancer	8.17e-05	0.00138	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Irinotecan—colon cancer	8.03e-05	0.0129	CcSEcCtD
Fluoxymesterone—Dexamethasone—PTGS2—colon cancer	7.97e-05	0.0567	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—colon cancer	7.95e-05	0.00134	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	7.88e-05	0.00133	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—colon cancer	7.83e-05	0.00132	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EP300—colon cancer	7.8e-05	0.00131	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	7.77e-05	0.00131	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	7.76e-05	0.00131	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Fluorouracil—colon cancer	7.69e-05	0.0123	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—EP300—colon cancer	7.6e-05	0.00128	CbGpPWpGaD
Fluoxymesterone—Alopecia—Capecitabine—colon cancer	7.45e-05	0.0119	CcSEcCtD
Fluoxymesterone—Progesterone—ABCB1—colon cancer	7.41e-05	0.0527	CrCbGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	7.39e-05	0.00124	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	7.21e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—colon cancer	7.2e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—colon cancer	7.2e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—colon cancer	7.19e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—colon cancer	7.17e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGFR3—colon cancer	7.11e-05	0.0012	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	7.02e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CDKN1A—colon cancer	7.01e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—Testosterone—ABCB1—colon cancer	7e-05	0.0498	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.95e-05	0.00117	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—colon cancer	6.9e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—colon cancer	6.87e-05	0.00116	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—colon cancer	6.86e-05	0.00115	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DLC1—colon cancer	6.84e-05	0.00115	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—colon cancer	6.79e-05	0.00114	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.79e-05	0.00114	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—ABCB1—colon cancer	6.78e-05	0.0482	CrCbGaD
Fluoxymesterone—Hypersensitivity—Vincristine—colon cancer	6.77e-05	0.0109	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—colon cancer	6.7e-05	0.00113	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CDKN1A—colon cancer	6.7e-05	0.00113	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—colon cancer	6.65e-05	0.00112	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Irinotecan—colon cancer	6.59e-05	0.0106	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—APC—colon cancer	6.53e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—colon cancer	6.53e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	6.46e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.46e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LGR5—colon cancer	6.43e-05	0.00108	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—colon cancer	6.43e-05	0.00108	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EP300—colon cancer	6.38e-05	0.00107	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—colon cancer	6.35e-05	0.00107	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Fluorouracil—colon cancer	6.31e-05	0.0101	CcSEcCtD
Fluoxymesterone—Haemoglobin—Methotrexate—colon cancer	6.3e-05	0.0101	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6.28e-05	0.00106	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CDKN1A—colon cancer	6.28e-05	0.00106	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—colon cancer	6.28e-05	0.00106	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Methotrexate—colon cancer	6.27e-05	0.0101	CcSEcCtD
Fluoxymesterone—Anxiety—Capecitabine—colon cancer	6.22e-05	0.00998	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—colon cancer	6.2e-05	0.00104	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—SRC—colon cancer	6.2e-05	0.00104	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—BRAF—colon cancer	6.14e-05	0.00103	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	6.12e-05	0.00103	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EP300—colon cancer	6.01e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	5.98e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	5.97e-05	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—colon cancer	5.96e-05	0.001	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—colon cancer	5.88e-05	0.00099	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—colon cancer	5.83e-05	0.00098	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—colon cancer	5.8e-05	0.000976	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EP300—colon cancer	5.76e-05	0.00097	CbGpPWpGaD
Fluoxymesterone—Headache—Vincristine—colon cancer	5.75e-05	0.00923	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	5.69e-05	0.000957	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.63e-05	0.000947	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.62e-05	0.000945	CbGpPWpGaD
Fluoxymesterone—Headache—Irinotecan—colon cancer	5.6e-05	0.00899	CcSEcCtD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—colon cancer	5.59e-05	0.000941	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—colon cancer	5.58e-05	0.000939	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	5.56e-05	0.000935	CbGpPWpGaD
Fluoxymesterone—Alopecia—Methotrexate—colon cancer	5.54e-05	0.00889	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.51e-05	0.000927	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—colon cancer	5.46e-05	0.000919	CbGpPWpGaD
Fluoxymesterone—Nausea—Vincristine—colon cancer	5.46e-05	0.00875	CcSEcCtD
Fluoxymesterone—AR—Gene Expression—HNF4A—colon cancer	5.44e-05	0.000915	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—colon cancer	5.43e-05	0.000914	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	5.41e-05	0.00091	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Capecitabine—colon cancer	5.38e-05	0.00862	CcSEcCtD
Fluoxymesterone—Headache—Fluorouracil—colon cancer	5.37e-05	0.00861	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	5.35e-05	0.000901	CbGpPWpGaD
Fluoxymesterone—Nausea—Irinotecan—colon cancer	5.31e-05	0.00852	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—colon cancer	5.23e-05	0.000881	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	5.23e-05	0.00088	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	5.2e-05	0.000875	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—colon cancer	5.13e-05	0.000864	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—colon cancer	5.12e-05	0.000862	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—colon cancer	5.09e-05	0.000857	CbGpPWpGaD
Fluoxymesterone—Nausea—Fluorouracil—colon cancer	5.09e-05	0.00816	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	4.98e-05	0.000838	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—colon cancer	4.91e-05	0.000826	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	4.84e-05	0.000814	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—colon cancer	4.84e-05	0.000814	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—colon cancer	4.81e-05	0.00081	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.78e-05	0.000804	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PIK3CA—colon cancer	4.72e-05	0.000794	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	4.71e-05	0.000793	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—colon cancer	4.71e-05	0.000793	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.62e-05	0.000778	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AXIN2—colon cancer	4.62e-05	0.000778	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—colon cancer	4.6e-05	0.000774	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—colon cancer	4.48e-05	0.000754	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Methotrexate—colon cancer	4.46e-05	0.00715	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—colon cancer	4.43e-05	0.000746	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PIK3CA—colon cancer	4.42e-05	0.000744	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Capecitabine—colon cancer	4.41e-05	0.00708	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—HRAS—colon cancer	4.36e-05	0.000734	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	4.34e-05	0.00073	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CDKN1A—colon cancer	4.33e-05	0.000729	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	4.33e-05	0.000728	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—colon cancer	4.3e-05	0.000723	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.24e-05	0.000714	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HNF4A—colon cancer	4.19e-05	0.000705	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HNF4A—colon cancer	4.13e-05	0.000694	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EP300—colon cancer	4.12e-05	0.000694	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—colon cancer	4.09e-05	0.000688	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SRC—colon cancer	4.01e-05	0.000675	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.01e-05	0.000674	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Methotrexate—colon cancer	4e-05	0.00642	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.9e-05	0.000657	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—colon cancer	3.9e-05	0.000657	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—colon cancer	3.86e-05	0.000649	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—colon cancer	3.85e-05	0.000648	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—colon cancer	3.78e-05	0.000636	CbGpPWpGaD
Fluoxymesterone—Headache—Capecitabine—colon cancer	3.75e-05	0.00602	CcSEcCtD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—colon cancer	3.72e-05	0.000626	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	3.68e-05	0.00062	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—colon cancer	3.63e-05	0.000611	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—colon cancer	3.61e-05	0.000608	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—colon cancer	3.59e-05	0.000604	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—colon cancer	3.58e-05	0.000603	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	3.56e-05	0.000599	CbGpPWpGaD
Fluoxymesterone—Nausea—Capecitabine—colon cancer	3.56e-05	0.0057	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—colon cancer	3.51e-05	0.000591	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—colon cancer	3.32e-05	0.000559	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Methotrexate—colon cancer	3.28e-05	0.00527	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CA—colon cancer	3.05e-05	0.000513	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.01e-05	0.000506	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—colon cancer	2.95e-05	0.000496	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—colon cancer	2.82e-05	0.000475	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—colon cancer	2.8e-05	0.000471	CbGpPWpGaD
Fluoxymesterone—Headache—Methotrexate—colon cancer	2.79e-05	0.00448	CcSEcCtD
Fluoxymesterone—Nausea—Methotrexate—colon cancer	2.65e-05	0.00425	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—colon cancer	2.49e-05	0.000419	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—colon cancer	2.36e-05	0.000397	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—colon cancer	2.15e-05	0.000363	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—colon cancer	2.12e-05	0.000357	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—colon cancer	1.82e-05	0.000306	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—colon cancer	1.79e-05	0.000302	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—colon cancer	1.35e-05	0.000227	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR3—colon cancer	1.34e-05	0.000225	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APC—colon cancer	1.23e-05	0.000206	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—BRAF—colon cancer	1.15e-05	0.000194	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—colon cancer	1.04e-05	0.000175	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—colon cancer	1.02e-05	0.000172	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—colon cancer	9.34e-06	0.000157	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—colon cancer	8.64e-06	0.000145	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—colon cancer	8.41e-06	0.000141	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—colon cancer	8.33e-06	0.00014	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CDKN1A—colon cancer	8.13e-06	0.000137	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EP300—colon cancer	7.74e-06	0.00013	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SRC—colon cancer	7.53e-06	0.000127	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—colon cancer	7.33e-06	0.000123	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—colon cancer	7.24e-06	0.000122	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—colon cancer	7.19e-06	0.000121	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—colon cancer	7.08e-06	0.000119	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—colon cancer	6.74e-06	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—colon cancer	6.73e-06	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—colon cancer	6.6e-06	0.000111	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—colon cancer	6.23e-06	0.000105	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CA—colon cancer	5.73e-06	9.63e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—colon cancer	5.54e-06	9.32e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—colon cancer	5.3e-06	8.91e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—colon cancer	4.68e-06	7.87e-05	CbGpPWpGaD
